You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

(R)-(11)C Rolipram

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dosimetry, Healthy Trial run by the NIMH ([C-11](R)-rolipram)

Completed
  • Dosimetry
  • Healthy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

Completed
  • Huntington Disease
  • [11C]CHDI-00485180-R
  • [11C]CHDI-00485626
  • Leuven, Belgium
    UZ Leuven
May 18, 2022

Nervous System Disease Trial run by the NIMH (Brain PET Imaging with 11C Rolipram, Whole Body PET Baseline with 11C Rolipram,

Completed
Has Results
  • Nervous System Disease
  • Brain PET Imaging with 11C Rolipram
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 24, 2020

Long-term Effects of COVID-19

Recruiting
  • COVID-19
  • SAR-CoV-2
  • (R)-1-(2-chlorophenyl)- N-[11C] ([11C] PK11195)
  • 2-(4-[11C]methylamino phenyl)-6-hydroxybenzothiazole (11C]6-OH-BTA-1 or [11C]PIB)
  • Jacksonville, Florida
    Mayo Clinic Florida
May 31, 2022

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Drug Dependence Trial in New Haven ([11-C]OMAR)

    Recruiting
    • Drug Dependence
    • [11-C]OMAR
    • New Haven, Connecticut
      Connecticut Mental Health Center
    Oct 14, 2021

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    Atopic Dermatitis Trial in Canada, United States (Abrocitinib)

    Recruiting
    • Atopic Dermatitis
    • Fountain Valley, California
    • +8 more
    Jan 25, 2023

    DLBCL, Transformed Follicular Lymphoma to DLBCL, Transformed Marginal Zone Lymphoma to DLBCL Trial in Columbus

    Recruiting
    • Diffuse Large B-Cell Lymphoma
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 23, 2022

    Amyotrophic Lateral Sclerosis Trial in Canada, United States (ANX005)

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • Phoenix, Arizona
    • +10 more
    Jul 1, 2022

    Neuroinflammation in COVID-19 and Depression

    Recruiting
    • Major Depressive Episode
    • Covid19
    • [18F]FEPPA PET scan
    • [11C]SL25.1188 PET scan
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health
    Apr 20, 2021

    Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

    Completed
    • Hyperkalemia
    • Alexander City, Alabama
    • +414 more
    Jan 11, 2022

    Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,

    Recruiting
    • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
    • +13 more
    • Scottsdale, Arizona
    • +2 more
    Jun 1, 2022

    Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, DLBCL

    Active, not recruiting
    Has Results
    • Adult Burkitt Lymphoma
    • +4 more
    • Chicago, Illinois
    • +4 more
    Feb 17, 2022

    Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)

    Completed
    Has Results
    • Plaque Psoriasis
    • Roflumilast Cream 0.3%
    • +2 more
    • Beverly Hills, California
    • +29 more
    Aug 31, 2022

    Intubation; Difficult or Failed, Sore-throat, Hoarseness Trial in Istanbul (Intubation using C-MAC D blade videolariyngoscope)

    Completed
    • Intubation; Difficult or Failed
    • +2 more
    • Intubation using C-MAC D blade videolariyngoscope
    • Istanbul, Turkey
      Yeditepe University
    Aug 21, 2023

    Depressive Disorder, Major, Anhedonia Trial in Worldwide (Aticaprant, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • Anhedonia
    • Birmingham, Alabama
    • +156 more
    Jan 31, 2023

    Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Lispro (U100), Insulin Glargine (U100))

    Completed
    • Type 2 Diabetes
    • Sheffield, Alabama
    • +134 more
    Nov 22, 2022

    Atherosclerotic Cardiovascular Disease, Symptomatic Atherosclerosis, Type2 Diabetes Trial in Worldwide (Inclisiran, Evolocumab)

    Completed
    • Atherosclerotic Cardiovascular Disease
    • +3 more
    • Jacksonville, Florida
    • +51 more
    Feb 7, 2022

    COVID-19, Immunodeficiency Trial (Paxlovid 5 days, Paxlovid 10 days, Tixagevimab and Cilgavimab)

    Not yet recruiting
    • COVID-19
    • Immunodeficiency
    • Paxlovid 5 days
    • +2 more
    • (no location specified)
    Oct 18, 2022

    Type2 Diabetes, Dyslipidemia Trial in Worldwide (K-877, Placebo)

    Terminated
    • Type2 Diabetes
    • Dyslipidemia
    • Birmingham, Alabama
    • +887 more
    Dec 20, 2022

    Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

    Recruiting
    • Mantle Cell Lymphoma
    • New Orleans, Louisiana
    • +5 more
    Dec 13, 2022

    Ann Arbor Stage III DLBCL, Ann Arbor Stage IIX (Bulky) DLBCL, Ann Arbor Stage IV DLBCL Trial in United States (drug, other,

    Suspended
    • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
    • +20 more
    • Tucson, Arizona
    • +110 more
    Jan 31, 2023

    Anus Tumors, Carcinoma, Squamous Cell, Anus Diseases Trial (Paclitaxel, Capecitabine, Mitomycins)

    Unknown status
    • Anus Neoplasms
    • +5 more
    • (no location specified)
    Feb 7, 2021

    Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis

    Active, not recruiting
    • Allergic Rhinitis Due to Dermatophagoides Farinae
    • +2 more
    • Sublingual allergy immunotherapy tablet
    • Placebo
    • Bakersfield, California
    • +116 more
    Dec 8, 2022